Dynavax Technologies Signs Agreement and Plan of Merger With Sanofi
I'm PortAI, I can summarize articles.
Dynavax Technologies has signed an Agreement and Plan of Merger with Sanofi, which will acquire Dynavax through a cash tender offer of $15.50 per share. The transaction is subject to a majority tender and regulatory approvals, with the merger expected to close under Delaware law, making Dynavax a wholly owned subsidiary of Sanofi. This deal aims to provide immediate cash value to Dynavax shareholders and integrate the company into Sanofi’s global platform.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments